113 results
8-K
EX-10.1
RGLS
Regulus Therapeutics Inc
14 Mar 24
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity
4:57pm
by the Indemnifying Party or by the Indemnified Party and the parties’ relative intent, knowledge, access to information and opportunity to correct
8-K
EX-99.2
RGLS
Regulus Therapeutics Inc
14 Mar 24
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity
4:57pm
).
Conference Call Information The Company will host a conference call and live audio webcast on March 12, 2024, at 8:30 am Eastern Time. To access the call … the investor relations section of the Company’s website. To access the telephone replay of the call, dial (877) 344-7529 (domestic) or (412) 317-0088
S-8
EX-99.5
RGLS
Regulus Therapeutics Inc
12 Jan 24
Registration of securities for employees
4:11pm
the Participant has access). By accepting any Award, the Participant consents to receive documents by electronic delivery and to participate in the Plan
8-K
EX-99.1
rzltr3 gb5q2pqc
14 Jun 23
Departure of Directors or Certain Officers
4:01pm
DEFA14A
lx0zqmu3vfrwfe5p74h
28 Apr 23
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
tbt4natdlnlujyltlv
13 Apr 23
Securities Purchase Agreement
4:05pm
8-K
EX-99.1
tz4l 59ru5
10 Nov 22
Regulus Therapeutics Reports Third Quarter 2022 Financial Results and Recent Updates
4:15pm
8-K
EX-99.1
ma8k9ek05
11 Aug 22
Regulus Therapeutics Reports Second Quarter 2022 Financial Results and Recent Updates
4:33pm
8-K
EX-99.1
rh9eiyx8mkm80py1mj4
12 May 22
Regulus Therapeutics Reports First Quarter 2022 Financial Results and Recent Updates
4:31pm
DEFA14A
cpn5m2jdv8ripiukh6b
27 Apr 22
Additional proxy soliciting materials
6:17am